Pakistan’s medicinal imports rise by 9.74pc
ISLAMABAD: Pakistan imported medicinal product worth $656.092 million during the first seven months of current fiscal year, showing growth of 9.74 per cent, when...
Pakistan’s retail pharma sector surpasses Rs1.049 trillion in salesÂ
Data from IQVIA reveals steep price hikes drive growth as medicine consumption shows minimal increase, raising concerns over affordability
Saudi investors exit Pakistan’s largest pharmacy chain. What happened and why?
From its origins as part of the Servis Group to multiple changes in ownership since its inception in 2005, Servaid has undergone an eventful two decades in existence
Pharmaceuticals: how the locals are beating the multinationals
In a heavily regulated market, the local players have learned to live with the price rules the way they are, while the foreign players still seem to have hope that things will change
Amoxil recall hits GSK Pakistan revenue in otherwise strong year
Deregulated drug pricing allowed the company to improve gross margins, but the recall still caused revenue to decline
Afghan trade halt hits Pakistan’s $200 million pharma exports, medicine containers struck at Torkham, Chaman borders
PPMA warns over 50 pharma firms face losses as temperature-sensitive medicines risk expiry; industry urges govt to allow exports on humanitarian grounds
At Searle, revenue growth is now about volumes, not just prices
The company has also managed to secure alternative input suppliers are disruption on trade with India
Pakistan’s pharmaceutical exports hit 34% growth in FY25, marking a two-decade high
Exports of locally produced medicines reach $457 million, with deregulation policy boosting growth
Senate panel alarmed as medicine prices jump 32% after price controls lifted
Health ministry reports some essential drugs have doubled in cost, prompting inquiry into deregulation impact; Pharmaceutical Manufacturers Association disputes the official figures
Citi Pharma submits offers for acquisition of leading pharma companyÂ
Non-binding offer is part of Citi’s strategic expansion plans to become largest pharma firmÂ
Searle to sell its entire shareholding in Pakistani subsidiary Â
Board approves sale of 90.61% stake to IJARA-led consortium
Searle Company to divest entire stake in Searle Pakistan Limited
Board approves disposal of 100% shareholding; negotiations for terms underway
BF Biosciences expands production, launches diabetes treatment, secures listing approval
Company receives approval for brownfield expansion and launches Sematide, a new diabetes treatment, while listing application is greenlit by SECP and PSX
OBS Pakistan amalgamates AGP with AitkenStuart
It is pertinent to mention that rumours had been circulating that OBS Pakistan was going through major restructuring and this acquisition by Searle comes as a surprise for the market.
Can Hamdard thrive in the era of the millennial consumer?
It is an ad that relies on contrasts: a product as traditionally Pakistani as Hamdard’s Rooh Afza being consumed by non-Pakistanis in New York’s...
